A Hidden Cause of Hypertransaminasemia: Liver Toxicity Caused by Chelidonium Majus L.: Report of Two Cases of Herb-Induced Liver Injury and Literature Review
- 30 May 2024
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 31 (4) , e382-e387
Abstract
Background: In instances where individuals manifest elevated transaminase levels without a clearly discernible cause, a comprehensive patient history proves invaluable in unveiling latent triggers. In this report, we present 2 cases of herb-induced liver injury (HILI) characterized by severe hypertransaminasemia attributed to the consumption of Chelidonium majus L. (also known as greater celandine [GC]), an agent considered an alternative therapeutic remedy. Areas of Uncertainty: Exploring the occurrence and range of clinical manifestations in HILI linked to Chelidonium majus L., while also investigating the potential triggers and predisposing factors for hepatotoxic reactions post Chelidonium majus L. usage, remains challenging due to the absence of definitive laboratory tests to identify the causative agent. Data Sources: Two case reports were detailed, and a systematic literature review using PubMed was conducted including published literature till March 2023. Moreover, a manual search of reference lists of pertinent articles was performed to identify any additional relevant missed publications. Results: In the first case, a 64-year-old woman presented with jaundice, revealing a 1-month history of using GC capsules to manage gallstones. Diagnostic assessment identified HILI, gallstones, and choledocolithiasis, with transaminase levels exceeding 1000 IU/L. After discontinuing GC and receiving intravenous therapy with amino acids and phospholipids, the patient's condition significantly improved. Subsequently, she underwent endoscopic common bile duct stone removal and cholecystectomy. In the second case, a 66-year-old woman presented with elevated liver function test results discovered incidentally during musculoskeletal pain evaluation. Upon further questioning, the patient disclosed regular consumption of GC tea for "health promotion." Following intravenous therapy using amino acids and phospholipids, her transaminase levels returned to normal. The literature review identified 38 cases of HILI associated with GC preparations, primarily in adult women aged 27–77 years, with a predominant reporting location in Germany. Various forms of GC were used, with treatment durations ranging from 1 week to a year. Discontinuation of GC generally led to recovery in these cases. Conclusion: Chelidonium majus L., a potent herb often used in alternative medicine, has significant hepatotoxic potential, requiring physicians to be vigilant in cases of unexplained liver injury.Keywords
This publication has 20 references indexed in Scilit:
- Incidence and risk factors of drug‐induced liver injuryLiver International, 2022
- Herb induced liver injury after using herbal medicineMedicine, 2019
- Review article: herbal and dietary supplement hepatotoxicityAlimentary Pharmacology & Therapeutics, 2012
- Greater Celandine hepatotoxicity: a clinical reviewAnnals of Hepatology, 2012
- Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reportsRegulatory Toxicology and Pharmacology, 2011
- Hepatotoxicity by drugs and dietary supplements: safety perspectives on clinical and regulatory issuesAnnals of Hepatology, 2009
- Hepatitis from Greater celandine (Chelidonium majus L.): Review of literature and report of a new caseJournal of Ethnopharmacology, 2009
- 58-jähriger Patient mit schwerer cholestatischer HepatitisDie Innere Medizin, 2006
- Acute Hepatitis Induced by Greater Celandine ( Chelidonium majus )Scandinavian Journal of Gastroenterology, 2003
- Acute hepatitis induced by greater celandine (Chelidonium majus)Gastroenterology, 1999